These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
61 related articles for article (PubMed ID: 292884)
1. Radical radiotherapy for carcinoma of the prostate. Smart RF N Z Med J; 1979 Oct; 90(645):285-7. PubMed ID: 292884 [TBL] [Abstract][Full Text] [Related]
2. Delayed/salvage radiation therapy in patients with elevated prostate specific antigen levels after radical prostatectomy. A long term follow-up. Medini E; Medini I; Reddy PK; Levitt SH Cancer; 1996 Sep; 78(6):1254-9. PubMed ID: 8826948 [TBL] [Abstract][Full Text] [Related]
3. Radical radiotherapy of localised prostate cancer: the relationship between radiation dose and survival. Magrini SM; Cellai E; Pertici M; Rossi F; Ponticelli P; Odantini R; Cappellini M; Biti GP Cancer Radiother; 1998; 2(4):351-8. PubMed ID: 9755748 [TBL] [Abstract][Full Text] [Related]
4. Radiation therapy of localized prostate cancer. Landmann C Ann Urol (Paris); 1994; 28(4):207-20. PubMed ID: 7979211 [TBL] [Abstract][Full Text] [Related]
5. The feasibility of dose escalation with three-dimensional conformal radiotherapy in patients with prostatic carcinoma. Zelefsky MJ; Leibel SA; Kutcher GJ; Kelson S; Ling CC; Fuks Z Cancer J Sci Am; 1995; 1(2):142-50. PubMed ID: 9166467 [TBL] [Abstract][Full Text] [Related]
6. Radiotherapy in the management of stage C carcinoma of the prostate. Carlton CE; Hudgins PT; Guerriero WG; Scott R Trans Am Assoc Genitourin Surg; 1975; 67():70-4. PubMed ID: 1233814 [TBL] [Abstract][Full Text] [Related]
7. External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores. Kupelian P; Katcher J; Levin H; Zippe C; Suh J; Macklis R; Klein E Cancer J Sci Am; 1997; 3(2):78-87. PubMed ID: 9099457 [TBL] [Abstract][Full Text] [Related]
8. Pelvic nodal dose escalation with prostate hypofractionation using conformal avoidance defined (H-CAD) intensity modulated radiation therapy. Hong TS; Tomé WA; Jaradat H; Raisbeck BM; Ritter MA Acta Oncol; 2006; 45(6):717-27. PubMed ID: 16938815 [TBL] [Abstract][Full Text] [Related]
9. Improved biochemical disease-free survival of men younger than 60 years with prostate cancer treated with high dose conformal external beam radiotherapy. Zelefsky MJ; Marion C; Fuks Z; Leibel SA J Urol; 2003 Nov; 170(5):1828-32. PubMed ID: 14532785 [TBL] [Abstract][Full Text] [Related]
10. Long-term prostate cancer control using palladium-103 brachytherapy and external beam radiotherapy in patients with a high likelihood of extracapsular cancer extension. Dattoli M; Wallner K; True L; Cash J; Sorace R Urology; 2007 Feb; 69(2):334-7. PubMed ID: 17320673 [TBL] [Abstract][Full Text] [Related]
11. [Radical radiotherapy of prostate carcinoma]. Kulhavý M; Kindlová E; Kovarík J Cas Lek Cesk; 2001 Jun; 140(11):328-31. PubMed ID: 11431851 [TBL] [Abstract][Full Text] [Related]
12. [Brachytherapy boost irradiation in the treatment of high risk, localised prostate cancer. Initial national experience in Hungary]. Agoston P; Major T; Somogyi A; Szûcs M; Danczig A; Lövey J; Polgár C; Fodor J; Németh G; Kásler M Magy Onkol; 2004; 48(1):81-8. PubMed ID: 15105901 [TBL] [Abstract][Full Text] [Related]
13. A randomized trial comparing radical prostatectomy plus endocrine therapy versus external beam radiotherapy plus endocrine therapy for locally advanced prostate cancer: results at median follow-up of 102 months. Akakura K; Suzuki H; Ichikawa T; Fujimoto H; Maeda O; Usami M; Hirano D; Takimoto Y; Kamoto T; Ogawa O; Sumiyoshi Y; Shimazaki J; Kakizoe T; Jpn J Clin Oncol; 2006 Dec; 36(12):789-93. PubMed ID: 17082219 [TBL] [Abstract][Full Text] [Related]
14. Toxicity after three-dimensional radiotherapy for prostate cancer on RTOG 9406 dose Level V. Michalski JM; Winter K; Purdy JA; Parliament M; Wong H; Perez CA; Roach M; Bosch W; Cox JD Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):706-13. PubMed ID: 15936549 [TBL] [Abstract][Full Text] [Related]
15. Year of treatment as independent predictor of relapse-free survival in patients with localized prostate cancer treated with definitive radiotherapy in the PSA era. Kupelian P; Thames H; Levy L; Horwitz E; Martinez A; Michalski J; Pisansky T; Sandler H; Shipley W; Zelefsky M; Zietman A; Kuban D Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):795-9. PubMed ID: 15925452 [TBL] [Abstract][Full Text] [Related]
16. Analysis of toxicity in patients with high risk prostate cancer treated with intensity-modulated pelvic radiation therapy and simultaneous integrated dose escalation to prostate area. Arcangeli S; Saracino B; Petrongari MG; Gomellini S; Marzi S; Landoni V; Gallucci M; Sperduti I; Arcangeli G Radiother Oncol; 2007 Aug; 84(2):148-55. PubMed ID: 17692416 [TBL] [Abstract][Full Text] [Related]
17. [Definitive radical radiotherapy in tumors of the prostate. Analysis of statistics]. Fumagalli M; Personeni A; Vavassori V; Bianchi N Radiol Med; 1988 Jun; 75(6):647-52. PubMed ID: 3291007 [TBL] [Abstract][Full Text] [Related]
18. A dose-escalation trial with the adaptive radiotherapy process as a delivery system in localized prostate cancer: analysis of chronic toxicity. Brabbins D; Martinez A; Yan D; Lockman D; Wallace M; Gustafson G; Chen P; Vicini F; Wong J Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):400-8. PubMed ID: 15667959 [TBL] [Abstract][Full Text] [Related]
19. Prostate-specific antigen (PSA) and radiotherapy in locally confined prostate cancer. Schaefer U; Micke O; Willich N Anticancer Res; 1999; 19(4A):2645-8. PubMed ID: 10470211 [TBL] [Abstract][Full Text] [Related]
20. Simultaneous radiotherapy for prostate cancer: 125I prostate implant followed by external-beam radiation. Critz FA; Levinson AK; Williams WH; Holladay CT; Griffin VD; Holladay DA Cancer J Sci Am; 1998; 4(6):359-63. PubMed ID: 9853134 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]